Aliqopa

(copanlisib)

Aliqopa 60 MG Injection

NO BLACK BOX WARNING

Dosage & administration

* Recommended dosage: 60 mg administered as a 1-hour intravenous infusion on Days 1, 8, and 15 of a 28-day treatment cycle on an intermittent schedule (three weeks on and one week off). Modify dosage for toxicity .
* Reduce ALIQOPA dose to 45 mg in patients with moderate hepatic impairment (Child-Pugh B) or to 30 mg in patients with severe hepatic impairment (Child-Pugh C) .
* See full prescribing information for important preparation and administration information .

Most viewed Aliqopa resources

OTHEREnroll in Patient Savings Program

biomarker testing

Aliqopa clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Aliqopa prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Aliqopa prior authorization resources

Most recent Aliqopa prior authorization forms

View By Payer

Verified: Sep 27, 2023Cigna - Aliqopa Prior Authorization Form

PDFComplete Letter of Medical Necessity

PDFCoverage Authorization Appeals

Learn More

Benefits investigation

PDFAliqopa Service Request Form

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Aliqopa financial assistance options

Co-pay savings program

commercial only

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

OTHEREnroll in Bridge Program

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFAliqopa Service Request Form

PDFBayer US Patient Assistance Program Application

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Aliqopa patient education

Getting started on Aliqopa

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

BRAND PAGEAbout Aliqopa

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFPatient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Other resources

Learn More

Aliqopa FAQs

How is the dosage of Aliqopa?Aliqopa is available in 1 dosages, including 60 mg Injection

What does Aliqopa treat?Aliqopa treats Follicular Lymphoma

What is Aliqopa made of?Aliqopa contains copanlisib which is a Kinase Inhibitor

How Is Aliqopa Administered?Aliqopa is administered as a Injectable

What Are The Aliqopa Mechanism Of Action?Aliqopa mechanism of action is Kinase Inhibitors

FAQ Data Source

Aliqopa

Dosage & administration

Most viewed Aliqopa resources

biomarker testing

Aliqopa clinical details

drug label

Aliqopa prescribing information

prior authorization

Aliqopa prior authorization resources

Most recent Aliqopa prior authorization forms

Benefits investigation

Reimbursement help (FRM)

financial assistance

Aliqopa financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Aliqopa patient education

Getting started on Aliqopa

Patient toolkit

Other resources

people also ask

Aliqopa FAQs